CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(19 sites)

Italy

Ospedali Riuniti di Ancona, Ancona

ASST Papa Giovanni XXIII, Bergamo

Oncologia Medica Policlinico Sant'Orsola - Malpighi, Bologna

ASST Spedali Civili, Brescia

Azienda Ospedaliera S. Croce e Carle, Cuneo